Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Superior Alternative to Pads and Tampons More
Compatible Permeation Enhancement Excipients: Enhancing Transmucosal and Transdermal Drug Delivery More
Acrux Advances Clinical Development of Investigational Testosterone Spray for Women: Testosterone MDTS® for the Treatment of Female Androgen Insufficiency More
Oestradiol Spray for Women: Oestradiol MDTS for the Treatment of Menopausal Symptoms More
Development of a Cellular and Animal Model for Infantile Haemangioma More
A Method of Guiding Oxygen Administration During Newborn Resuscitation More
Improvement on Current Electronic Stethoscopes: Separation of Foetal Phonocardiograms of a Multi-Foetal Pregnancy More
CeaProve®: A Fast, Accurate and Easy Point-of-care Detection Screening of Pre-diabetes and Type 2 Diabetes More
Development of a Novel Treatment of Bedsores and Other Dermal Ulcers: A Spray Formulation Containing Recombinant Human Basic Fibroblast Growth Factor More
Method for Producing and Manipulating Intestinal Organotypic Culture More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2010 - 414 pages - $690
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Jul 2005 - 52 pages - $515
Nov 2011 - 7 pages - $3,835
Feb 2009 - 242 pages - $690
Apr 2010 - 5 pages - $500
Apr 2011 - 25 pages - $500
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us